Treatment of asthma with drugs modifying the leukotriene pathway.
Drazen
J M
JM
Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA.
Israel
E
E
O'Byrne
P M
PM
D018927:Anti-Asthmatic Agents / Q000627:therapeutic use*; D001094:Arachidonate 5-Lipoxygenase / Q000378:metabolism; D001249:Asthma / Q000188:drug therapy* / Q000209:etiology; D001993:Bronchodilator Agents / Q000627:therapeutic use; D002908:Chronic Disease; D006801:Humans; D020024:Leukotriene Antagonists / Q000627:therapeutic use*; D015289:Leukotrienes / Q000378:metabolism / Q000502:physiology*; D018077:Receptors, Leukotriene / Q000187:drug effects / Q000502:physiology
D018927:Anti-Asthmatic Agents; D001993:Bronchodilator Agents; D020024:Leukotriene Antagonists; D015289:Leukotrienes; D018077:Receptors, Leukotriene; D001094:Arachidonate 5-Lipoxygenase